Breast Imaging Classification and Management

Core BI-RADS Categories and Their Clinical Significance

The American College of Radiology recommends a standardized framework for radiologists to categorize breast imaging findings into seven distinct categories (0-6), each with specific malignancy risk estimates and management recommendations that directly guide clinical decision-making 1
Category 0 is indicated when additional imaging evaluation is needed before final assessment can be made, and is almost exclusively used in screening situations when spot compression, magnification views, or ultrasound are required 2, 1
Category 1 is assigned when no abnormalities are detected, and management involves resuming routine annual screening mammography 2, 1
Category 2 is used for definitively benign findings, and management involves resuming routine annual screening mammography 1, 2, 3
Category 3 is assigned when the malignancy risk is less than 2%, and management involves initial follow-up at 6 months with diagnostic unilateral mammography, then every 6-12 months for 1-2 years 2, 1, 4
Category 4 is used for suspicious abnormalities, and biopsy is the recommended management 1, 2, 3
Category 5 is assigned when the malignancy probability is ≥95%, and tissue diagnosis via core needle biopsy is mandatory 1, 2, 3
Category 6 is reserved for lesions with biopsy-confirmed malignancy prior to definitive treatment, and management follows breast cancer treatment guidelines 1, 2, 3

The American College of Radiology recommends ultrasound as the initial imaging modality of choice for women under 30 years, with diagnostic mammography added only if ultrasound shows suspicious findings or patient has BRCA/genetic mutations 5
For women 30-39 years, either ultrasound or diagnostic mammography/DBT can serve as initial imaging, with sensitivity of ultrasound exceeding mammography in this age group 5
For women ≥40 years, diagnostic mammography or DBT is the appropriate initial imaging, with ultrasound added after mammography if findings are suspicious or if targeted correlation is needed 6
Immediate biopsy of BI-RADS 3 lesions is reasonable in specific clinical scenarios, including high-risk patients, patients awaiting organ transplant, patients with known synchronous cancers, patients attempting pregnancy, and situations of extreme patient anxiety that biopsy would alleviate 6, 4

The American College of Radiology emphasizes supplemental screening in dense breasts, with women with extremely dense tissue having 4-6 fold increased breast cancer risk compared to fatty tissue 7
Mammography sensitivity is decreased in dense tissue, with increased interval cancer rates, and breast MRI and abbreviated breast MRI (AB-MRI) are usually appropriate for intermediate-risk women with dense tissue 7
For high-risk women, breast MRI or AB-MRI is usually appropriate regardless of density 7

The overall assessment is based on the most worrisome finding when multiple abnormalities are identified, and BI-RADS categories may change based on subsequent imaging findings 1
Pathology-imaging concordance is essential when biopsies are performed, and if pathology and imaging are discordant, repeat imaging and/or additional tissue sampling is mandatory 1, 4